Precipio (PRPO) EBT Growth (1y) (2011 - 2026)
Precipio (PRPO) EBT Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn | 12.58% |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn | 64.58% |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn | 33.21% |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn | 56.92% |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn | -6.81% |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn | 15.14% |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn | -15.03% |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn | 16.39% |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn | 26.81% |
| 10 | Precipio | 51.56 Mn | 48.49 Mn | 3.14 Mn | -395.95% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -395.95% |
| Dec 31, 2025 | 244.11% |
| Sep 30, 2025 | 87.38% |
| Jun 30, 2025 | 106.07% |
| Mar 31, 2025 | 57.48% |
| Dec 31, 2024 | -139.46% |
| Sep 30, 2024 | 56.98% |
| Jun 30, 2024 | 46.79% |
| Mar 31, 2024 | 31.39% |
| Dec 31, 2023 | 140.52% |
| Sep 30, 2023 | 54.14% |
| Jun 30, 2023 | -7.25% |
| Mar 31, 2023 | 33.90% |
| Dec 31, 2022 | -3.68% |
| Sep 30, 2022 | -71.14% |
| Jun 30, 2022 | 28.97% |
| Mar 31, 2022 | -215.92% |
| Dec 31, 2021 | -17.82% |
| Sep 30, 2021 | 43.68% |
| Jun 30, 2021 | -34.86% |